UBS Group’s Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 HTPA.WS Stock Holding History

UBS Group’s Portfolio HTPA.WS Stock Details HTPA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-961	Closed	–	–	11853
2022 Q3	$0	Sell	961 -3,233	-77%	-$221	﹤0.01%	11597
2022 Q2	$1K	Hold	4,194	–	–	﹤0.01%	10175
2022 Q1	$1K	Sell	4,194 -4,032	-49%	-$4.21K	﹤0.01%	10099
2021 Q4	$13K	Buy	+8,226	New	+$14.7K	﹤0.01%	8519
2021 Q3	–	Sell	-633	Closed	-$1K	–	10492
2021 Q2	$1K	Buy	633 +115	+22%	+$112	﹤0.01%	9286
2021 Q1	$1K	Buy	+518	New	+$885	﹤0.01%	8851

UBS Group's HTPA.WS Position: Q4 2022 in Review

UBS Group sold out of Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (HTPA.WS) in Q4 2022, closing a stake of 961 shares.

UBS Group first reported a position in HTPA.WS in Q1 2021 and held it in 6 quarters. The position peaked at $13K in Q4 2021. 0 funds tracked by Wall St. Rank hold HTPA.WS as of Q4 2022.

UBS Group reported no remaining Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
UBS Group sold 961 Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2022.
UBS Group first reported a position in Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2021 and held it in 6 quarters.
UBS Group's Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $13K in Q4 2021.
0 funds tracked by Wall St. Rank held Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.